After hours: December 27 at 6:40:00 PM EST Loading Chart for AVY ...
EC-5026 is under clinical development by Eicosis and currently in Phase I for Inflammatory Pain. According to GlobalData, Phase I drugs for Inflammatory Pain have an 81% phase transition success rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback